New drug GEn-1124 tested in healthy volunteers for safety and body processing
NCT ID NCT07185113
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 36 times
Summary
This early-stage study tested a single oral dose of GEn-1124 in 6 healthy adult men to see how the body absorbs and processes the drug. Participants stayed in the clinic for 2 days and had follow-up phone calls. The main goal was to measure drug levels and check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New Zealand Clinical Research (NZCR)
Christchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.